Full-Time

Supplier Quality Engineer

Hyperfine

Hyperfine

51-200 employees

Portable bedside MRI system for hospitals

Compensation Overview

$107k - $123k/yr

+ Corporate bonus + Equity plans

No H1B Sponsorship

Guilford, CT, USA

In Person

Up to 15% domestic and international travel required.

Bachelor's

Category
QA & Testing (1)
Required Skills
Microsoft Office
ERP
Six Sigma
Risk Management
Data Analysis

Get referred to Hyperfine

See people who can refer or advise you

Requirements
  • Strong working knowledge of 21 CFR Part 820, ISO 13485, ISO 14971 principles, and applicable medical device regulatory requirements.
  • Demonstrated leadership in supplier quality management, supplier audits, nonconformances, corrective and preventive actions, supplier corrective action requests, and risk management activities.
  • Experience planning, conducting, and managing supplier audits, including audit reporting, follow-up, and effectiveness verification.
  • Strong analytical and problem-solving skills, including root cause analysis, corrective and preventive action, change management, risk management, Six Sigma methodologies, statistical analysis, and data-driven decision making.
  • Proficiency with Microsoft Office, enterprise resource planning systems, and electronic quality management system platforms.
  • Ability to communicate effectively and influence stakeholders across all levels of the organization and with external suppliers.
  • Strong technical writing, communication, and data analysis skills.
  • Five to seven years of experience in a quality role within a regulated industry.
  • Ability to sit, stand, walk, and perform computer-based work for extended periods.
  • Ability to use standard office equipment, including computers, telephones, printers, and scanners.
  • Ability to work in manufacturing, warehouse, and supplier environments while complying with applicable safety and personal protective equipment requirements.
  • Ability to occasionally lift and carry materials weighing up to 25 pounds.
  • Ability to periodically access manufacturing, warehouse, and supplier facilities.
  • Ability to travel domestically and internationally, as required, up to 15%.
  • Ability to work additional hours as needed to support audits, supplier activities, and business objectives.
Responsibilities
  • Establish and maintain the supplier qualification process and associated documentation, including supplier audits, supplier agreements, the Approved Supplier List, and supplier scorecards.
  • Conduct product release activities, including review and approval of supplier Device History Records.
  • Collaborate with Operations, Engineering, and Research and Development to ensure that products meet applicable quality and regulatory requirements, including risk assessment, disposition of deviations, rework activities, and Visual Assembly Process documentation.
  • Analyze supplier quality and internal manufacturing performance metrics to identify trends, drive continuous improvement initiatives, and support process standardization efforts.
  • Own and manage nonconformances, corrective and preventive actions, and supplier corrective action requests, as assigned.
  • Support maintenance of quality system documentation.
  • Support and participate in internal and external audits.
Desired Qualifications
  • A BA/BS degree in a technical discipline, with equivalent experience considered in lieu of a higher degree.
  • Supplier auditing and supplier management experience within a regulated industry.
  • ASQ Certified Quality Auditor, Certified Quality Engineer, or Certified Six Sigma Green Belt.
  • ISO 13485 or Medical Device Single Audit Program auditor training.

Hyperfine creates medical imaging tools for hospitals, focusing on the Swoop system, the first FDA-cleared portable ultra-low field MRI that can image a patient’s brain at the bedside. How it works: a compact, portable MRI device is brought to the patient in settings like intensive care units, performing brain scans without moving the patient to a radiology suite. The open, safe design allows family members to stay nearby during imaging. Differentiation: it is already FDA-cleared and designed for point-of-care use, enabling bedside decision-making, faster treatment decisions, quicker discharges, and more efficient use of hospital staff and resources at a lower cost compared to traditional MRI workflows. Revenue model: Hyperfine sells the Swoop system and related services to hospitals, clinics, and other healthcare facilities. Goal: improve patient care by bringing diagnostic imaging directly to patients, increasing access to timely brain imaging and streamlining clinical workflows.

Company Size

51-200

Company Stage

IPO

Headquarters

Guilford, Connecticut

Founded

2014

Get referred to Hyperfine

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 revenue rose 45% to $3.9 million; 12 systems sold.
  • Europe and the U.K. launched Model 2 in Q2 2026; first sales landed.
  • Contrast PMR enrollment reached 75% in August 2026, targeting FDA submission by year-end.

What critics are saying

  • March 18, 2026 Horizon loan charges 10.75% minimum interest and heavy covenants.
  • Hyperfine filed S-3 for 1,083,335 warrant shares; dilution hits after 2026 draws.
  • If contrast-label FDA submission slips past 2026, office revenue stalls and reimbursement stays constrained.

What makes Hyperfine unique

  • Hyperfine owns the only FDA-cleared portable brain MRI, Swoop, in bedside settings.
  • Model 2 adds Optive AI DWI; FDA cleared December 2025, CE/UKCA April 2026.
  • AIIMS New Delhi and Yale PRIME validate differentiated point-of-care workflows in 2026.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Hybrid Work Options

Wellness Program

Mental Health Support

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

-3%

2 year growth

1%
Yahoo Finance
Aug 7th, 2026
Hyperfine revenue surges 45% to $3.9M with 50% growth in system sales

Hyperfine reported second-quarter 2026 revenue of $3.9 million, up 45% year-over-year, marking its second-highest quarter ever. The medical imaging company sold 12 systems, a 50% increase from the prior year, with strong international contributions. Gross margin exceeded 50% for the fourth consecutive quarter, reaching 50.7%. The company posted a net loss of $9.3 million, though this included non-cash warrant liability losses. Cash burn improved 9% in the first half compared to the previous year. Hyperfine ended the quarter with $43.5 million in cash, extending its runway into 2028. The company is expanding internationally, achieving CE and UKCA approvals and entering India. It plans to submit for FDA contrast labelling approval by year-end, which could open new reimbursement opportunities. Management expects significant second-half revenue growth driven by hospital budget cycles, office placements, and new software releases.

Clinical Trials Arena
May 26th, 2026
Hyperfine's portable MRI cuts emergency scan wait times by 6.35 hours in PRIME study

Hyperfine has presented data showing its Swoop portable MRI system significantly reduces imaging wait times in emergency departments. The PRIME study, conducted at Yale School of Medicine with 100 patients, demonstrated a median time from imaging order to scan start of 1.28 hours with Swoop, compared to 7.76 hours with conventional MRI—a difference of 6.35 hours. FDA-cleared in 2020, the 1,400-pound wheeled Swoop system operates via tablet and requires no specialised MRI personnel. The device offers an alternative when fixed MRI machines are inaccessible, particularly for brain-related emergencies. The data was presented at the Society for Academic Emergency Medicine conference in May 2026. The announcement follows Hyperfine's $40 million loan facility from Horizon Technology in March 2026 to expand Swoop's reach across healthcare settings.

Yahoo Finance
May 13th, 2026
Hyperfine Q1 revenue surges 83% to $3.9M as portable MRI maker narrows loss and reaffirms $20M-$22M full-year outlook

Hyperfine reported first-quarter revenue of $3.9 million, up 83% year over year, driven by adoption of its next-generation Swoop portable MRI system. The company sold 10 units in the quarter, with most being next-generation systems. Gross margin expanded to 50.7% from 41.3%, whilst net loss narrowed to $8.6 million. Hyperfine ended the quarter with $40.8 million in cash, supported by an initial $15 million debt tranche. The company reiterated full-year 2026 guidance for revenue of $20 million to $22 million and gross margin of 50% to 55%. Management highlighted pipeline strength in hospitals, neurology offices and international markets, plus progress towards a potential FDA submission for contrast-enhanced MRI use by end-2026.

Yahoo Finance
May 13th, 2026
Hyperfine revenue surges 83% to $3.9M as gross margin tops 50% for third consecutive quarter

Hyperfine Inc reported an 83% year-over-year revenue increase to $3.9 million for Q1 2026, with gross margins reaching 51% for the third consecutive quarter above 50%. The medical imaging company achieved CE and UKCA marks for its next-generation subsystem and advanced DWI Optiv AI software, enabling international expansion. Despite revenue growth, Hyperfine posted a net loss of $8.6 million and burnt through $8.8 million in cash during the quarter. The company maintains a cash position of $40.8 million, providing runway into 2028. Hyperfine's contrast PMR study enrollment has surpassed 50% of its target, supporting a potential FDA submission by end-2026. The company is focusing on larger medical offices and integrated delivery networks for its second-generation system deployments.

Associated Press
Apr 29th, 2026
India's AIIMS New Delhi deploys first portable MRI for bedside brain imaging

Hyperfine has introduced its Swoop portable MRI system at the All India Institute of Medical Sciences (AIIMS) in New Delhi, marking India's first deployment of bedside brain imaging technology for routine clinical use. The FDA-cleared, AI-powered system is now performing brain scans under Dr Shailesh Gaikwad's leadership at AIIMS's Centre for Neurological Conditions. The Swoop system addresses critical gaps in India's healthcare infrastructure by bringing MRI directly to patients' bedsides without requiring dedicated rooms, specialised power or patient transport. It supports neurological care across stroke units, trauma centres, intensive care units and neonatal wards. Radiosurgery Global serves as the exclusive distributor in India. The deployment establishes a foundation for clinical research, with AIIMS New Delhi positioned to generate real-world evidence for point-of-care brain imaging adoption across the country.